96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

713 trials found

diseases per page:

Showing 1 to 10 of 713 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05284136 (ClinicalTrials.gov)	April 1, 2022	28/2/2022	Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease	Prospective rAndomized Controlled tRial of Crohn's diseAse Exclusion Diet vs corticosteroIds in pati ...	Crohn Disease	Dietary Supplement: Crohn's disease exclusion diet (CDED);Drug: Oral prednisolone	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	16 Years	70 Years	All	80	Phase 2/Phase 3	France;Netherlands
2	NCT04456517 (ClinicalTrials.gov)	March 1, 2022	29/6/2020	Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy	REACT Trial: A Randomized, Double Blind, Placebo-controlled, Crossover Study of Ranolazine for the T ...	Crohn's Disease;Inflammatory Bowel Disease	Drug: Ranolazine;Drug: Placebo	Vanderbilt University Medical Center	NULL	Enrolling by invitation	18 Years	N/A	All	16	Phase 2	United States
3	NCT04779320 (ClinicalTrials.gov)	February 28, 2022	1/3/2021	A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Crohn's Disease (CD)	Drug: Vedolizumab IV	Takeda	NULL	Not yet recruiting	2 Years	17 Years	All	120	Phase 3	NULL
4	NCT04777656 (ClinicalTrials.gov)	February 2022	26/2/2021	Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Un ...	Randomized Trial for Unstable Pediatric Crohn's Disease Patients Comparing the Use of Crohn's Diseas ...	Crohn's Disease	Dietary Supplement: Phase1 : CDED/Modulen™IBD® + Maintenance therapy;Dietary Supplement: Phase2 and ...	Assistance Publique - Hôpitaux de Paris	URC-CIC Paris Descartes Necker Cochin;MICALIS Institute	Not yet recruiting	6 Years	17 Years	All	120	Phase 3	France
5	JPRN-jRCT2071210031	15/01/2022	01/06/2021	A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Crohn's Disease	Induction Period: Participants >=30 kg, Vedolizumab300 mg Vedolizumab300 mg, intravenous (IV) infusio ...	Shikamura Mitsuhiro	NULL	Pending	>= 2age old	<= 17age old	Both	120	Phase 3	United States;Australia;Belgium;Bosnia;Croatia;Czech Republic;Hungary;Germany;Italy;Israel;Lithuania ...
6	NCT04924270 (ClinicalTrials.gov)	January 2022	7/6/2021	Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diag ...	Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatmen ...	Rheumatoid Arthritis;Reactive Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Gouty Arthritis;P ...	Biological: Faecal microbiota transplantation;Other: Placebo	Torkell Ellingsen	Region of Southern Denmark;University of Southern Denmark	Not yet recruiting	18 Years	70 Years	All	200	Phase 2	NULL
7	EUCTR2019-001866-14-IT (EUCTR)	21/12/2021	12/10/2021	Open-label Extension Study of Brazikumab in Crohn's Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely A ...	Moderately to Severely Active Crohn's Disease. MedDRA version: 20.0;Level: LLT;Classification code 1 ...	Product Name: Brazikumab Product Code: [MEDI2070] INN or Proposed INN: ( L ) ASCORBATO DI CALCIO Other ...	ASTRAZENECA AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
8	EUCTR2020-004775-40-HR (EUCTR)	07/12/2021	16/12/2021	A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of O ...	A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of O ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: Etrasimod Product Code: APD334 INN or Proposed INN: etrasimod L-arginine Other descriptive ...	Arena Pharmaceuticals Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1265	Phase 2;Phase 3	Belarus;Portugal;Philippines;Slovakia;Greece;Thailand;Ukraine;Chile;Italy;India;France;Puerto Rico;D ...
9	NCT04186247 (ClinicalTrials.gov)	December 2021	2/12/2019	Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)	Personalized AZithromycin/metronidAZole, in Combination With Standard Induction Therapy, to Achieve ...	Crohn Disease;Pediatric Crohns Disease	Drug: Azithromycin;Drug: Metronidazole;Other: Standard of Care	University of North Carolina, Chapel Hill	Crohn's and Colitis Foundation;University of Amsterdam	Not yet recruiting	3 Years	17 Years	All	20	Phase 2	United States;Canada;Israel;Netherlands
10	EUCTR2021-000092-37-PL (EUCTR)	19/11/2021	17/08/2021	A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ...	A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: PRA023 INN or Proposed INN: Not yet assigned Other descriptive name: PRA023	Prometheus Biosciences, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 2	Belarus;United States;Czechia;Ukraine;Israel;Russian Federation;France;Czech Republic;Canada;Poland; ...

First Previous1 2 3 4 5…72Next Last